IMAB Other Non Cash Items vs Begin Period Cash Flow Analysis
| IMAB Stock | USD 0.95 0.01 1.06% |
I Mab financial indicator trend analysis is infinitely more than just investigating I Mab recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether I Mab is a good investment. Please check the relationship between I Mab Other Non Cash Items and its Begin Period Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.
Other Non Cash Items vs Begin Period Cash Flow
Other Non Cash Items vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of I Mab Other Non Cash Items account and Begin Period Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between I Mab's Other Non Cash Items and Begin Period Cash Flow is -0.19. Overlapping area represents the amount of variation of Other Non Cash Items that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of I Mab, assuming nothing else is changed. The correlation between historical values of I Mab's Other Non Cash Items and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Non Cash Items of I Mab are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Other Non Cash Items i.e., I Mab's Other Non Cash Items and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.19 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Other Non Cash Items
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most indicators from I Mab's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into I Mab current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.The current year's Selling General Administrative is expected to grow to about 521.3 M, whereas Tax Provision is forecasted to decline to 0.00.
| 2022 | 2023 | 2024 (projected) | Interest Expense | 1.3K | 101.9K | 96.8K | Depreciation And Amortization | 25.3M | 23.9M | 20.6M |
I Mab fundamental ratios Correlations
Click cells to compare fundamentals
I Mab Account Relationship Matchups
High Positive Relationship
High Negative Relationship
I Mab fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 1.7B | 6.3B | 5.6B | 4.1B | 2.6B | 3.7B | |
| Short Long Term Debt Total | 132.5M | 13.6M | 112.5M | 75.0M | 18.9M | 17.9M | |
| Other Current Liab | 531.7M | 567.4M | 593.3M | 637.3M | 371.9M | 463.9M | |
| Total Current Liabilities | 588.5M | 576.1M | 624.0M | 659.7M | 411.8M | 534.5M | |
| Total Stockholder Equity | (2.0B) | 5.6B | 4.6B | 3.0B | 242.4M | 230.3M | |
| Other Liab | 2.5M | 3.9M | 125.0M | 335.8M | 386.2M | 405.5M | |
| Net Tangible Assets | (1.3B) | (2.3B) | 5.3B | 4.3B | 5.0B | 5.2B | |
| Property Plant And Equipment Net | 46.5M | 40.3M | 158.5M | 124.0M | 11.7M | 11.1M | |
| Current Deferred Revenue | 3.9M | 7.5M | 2.4M | 8.7M | 32.6M | 34.2M | |
| Net Debt | (1.0B) | (4.7B) | (3.4B) | (3.1B) | (2.0B) | (2.1B) | |
| Retained Earnings | (2.5B) | (2.0B) | (4.4B) | (6.8B) | (8.3B) | (7.9B) | |
| Accounts Payable | 67.7M | (3.9M) | (2.4M) | (33.1M) | (29.8M) | (28.3M) | |
| Cash | 1.1B | 4.8B | 3.5B | 3.2B | 302.1M | 287.0M | |
| Non Current Assets Total | 376.3M | 990.1M | 847.7M | 447.2M | 276.3M | 262.5M | |
| Non Currrent Assets Other | 18.3M | 2.0M | 26.6M | 10.9M | 246.2M | 258.5M | |
| Other Assets | 18.3M | 2.0M | 26.6M | 237.3M | 272.9M | 286.6M | |
| Cash And Short Term Investments | 1.2B | 4.8B | 4.3B | 3.4B | 2.3B | 2.9B | |
| Net Receivables | 55.9M | 130.5M | 286.9M | 4.8M | 18.0M | 17.1M | |
| Common Stock Shares Outstanding | 57.8M | 68.4M | 76.0M | 82.5M | 83.2M | 71.8M | |
| Short Term Investments | 32M | 31.5M | 753.2M | 235.4M | 143.2M | 269.9M | |
| Liabilities And Stockholders Equity | 1.7B | 6.3B | 5.6B | 4.1B | 2.6B | 3.7B | |
| Non Current Liabilities Total | 3.2B | 130.5M | 417.6M | 405.6M | 483.0M | 458.8M | |
| Capital Lease Obligations | 14.3M | 13.6M | 112.5M | 56.0M | 45.0M | 37.9M | |
| Inventory | (55.9M) | (422.9M) | 27.2M | (80.3M) | (18.0M) | (18.9M) | |
| Other Current Assets | 191.8M | 195.5M | 190.8M | 172.5M | 47.1M | 44.8M | |
| Other Stockholder Equity | (2.7B) | 5.7B | 9.1B | 1.2B | 8.3B | 8.7B | |
| Total Liab | 3.8B | 706.6M | 1.0B | 1.1B | 894.8M | 1.4B | |
| Net Invested Capital | (1.9B) | 5.6B | 4.6B | 3.0B | 1.8B | 1.9B | |
| Property Plant And Equipment Gross | 46.5M | 40.3M | 158.5M | 124.0M | 156.4M | 90.5M | |
| Total Current Assets | 1.4B | 5.3B | 4.8B | 3.6B | 2.3B | 3.2B | |
| Accumulated Other Comprehensive Income | 70.1M | (50.8M) | (186.5M) | 216.7M | 298.3M | 313.2M | |
| Net Working Capital | 772.8M | 4.8B | 4.2B | 3.0B | 1.9B | 2.6B | |
| Short Term Debt | 56.8M | (33.6M) | 30.7M | 22.4M | 7.3M | 7.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether I Mab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of I Mab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of I Mab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on I Mab Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of I Mab. If investors know IMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about I Mab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 0.043 | Quarterly Revenue Growth (0.62) | Return On Assets (0.29) | Return On Equity (0.72) |
The market value of I Mab is measured differently than its book value, which is the value of IMAB that is recorded on the company's balance sheet. Investors also form their own opinion of I Mab's value that differs from its market value or its book value, called intrinsic value, which is I Mab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because I Mab's market value can be influenced by many factors that don't directly affect I Mab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between I Mab's value and its price as these two are different measures arrived at by different means. Investors typically determine if I Mab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, I Mab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.